fda compounding restrictions bpc-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank Exciting news for peptides coming

Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! BREAKING: U.S. Regulators to Review Controversial Peptides Backed by RFK Jr. U.S. health regulators are preparing to review whether several controversial peptide compounds should be allowed to be made by compounding

SKU: 51266057443 · From clintoncounty708.com